Research Grant RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- Acoustic, Behavioral and Foraging Ecology of Cetaceans off the Coast of Brazil A Baseline Study
- Acoustofluidic Separation, Purification and Raman Spectral Fingerprinting of Single EVs: From Cell of Origin to Target Cell and Biofluids
- Acquisition And Characterization Of Alloantisera & Molecu.
- Acquisition And Characterization Of Alloantisera And Moleu
- Acquisition of a Four-Circle X-ray Diffraction System - Chang-Beom Eom
- Acquisition of an Inductively Coupled Mass Spectrometer
- Acquisition Of An Ultra High Field Nmr Spectrometer
- Acquisition Of An Ultra High Field Spectrometer
- Acquisition of Appetite
- Acquisition of FDG PET Registry Data (NOPR Data Audit) 20-DKE-12
- Acquisition of Growth Chambers for the National Phytotron
- Acquisition Of Phosphorimager
- ACRIN Chair Agreement
- ACRIN Chair Agreement
- ACRIN Committee or Subcommittee Chair Agreement
- ACRIN MR Physics Center of Excellence
- ACRIN MR Physics Center of Excellence
- ACS Country Project
- ACT with cystic fibrosis
- ACTG A5327 Protocol Chair Support (PCS)
- ACTG EIA-Luminex Biomarker Supplement (Phase I)
- ACTG, Aids Clinical Trials Group
- ACTG, Aids Clinical Trials Group Hepatitis TSG Vice-Chair
- ACTION EQOL STUDY
- Actions of Angiotensin II Along the Nephron to Regulate Blood Pressure
- ACTIV 4a - A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in Hospitals Adults with COVID-19
- ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
- ACTIV-6: COVID-19 Outpatient Randomized Trial to Evaluate Efficacy of Repurposed Medications
- Activation & Function Of Human Cam Kinase Iv In T-Cell